soman has been researched along with phenobarbital sodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, SR; Bzdega, T; Der, EK; Farago, PR; Hark, TJ; Janczura, KJ; Lavin, KM; Lee, JC; Lee, MJ; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP | 1 |
| Chen, H; Flora, MN; Guo, H; Liu, J; McCabe, JT; McDonough, JH; Myers, TM; Van Shura, K | 1 |
2 other study(ies) available for soman and phenobarbital sodium
| Article | Year |
|---|---|
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamate Carboxypeptidase II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recognition, Psychology; Risperidone; Schizophrenia; Soman; Urea | 2012 |
N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
Topics: Animals; Brain; Carboxypeptidases; Cell Death; Chemical Warfare Agents; Chromatography, High Pressure Liquid; Dipeptides; Disease Models, Animal; Enzyme Inhibitors; Male; Neurons; Neuroprotective Agents; Organophosphate Poisoning; Organophosphorus Compounds; Rats, Sprague-Dawley; Signal Transduction; Soman; Time Factors | 2015 |